Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2023, Vol. 43 Issue (10): 120-128    DOI: 10.13523/j.cb.2303037
    
Evaluation of Biomedical Industry Technological Innovation Capability Based on High-value Patents
WANG Li-wei,YUAN Yin-chi,MAO Kai-yun,LU Jiao**()
Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China
Download: HTML   PDF(493KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To evaluate the biomedical industry technological innovation capability of major provinces (cities) in China based on high-value patents. Methods: Firstly, based on the standards put forward by Chinese National Intellectual Property Administration, the high-value patents are defined. Secondly, according to the characteristics of high-value patents, the evaluation indicators are selected from three dimensions: industrial technology innovation investment, industrial technology innovation output and industrial technology innovation quality. Finally, the weight is determined by the analytic hierarchy process (AHP) method. Results: Using the established indicator system, the biomedical industry technological innovation capability of Jiangsu, Beijing, Guangdong, Shandong, Zhejiang and Shanghai were evaluated in three stages. It was found that the biomedical industry technological innovation capability of Jiangsu and Guangdong have been constantly improved, while the capability of Shandong and Zhejiang are unstable and the capability of Beijing and Shanghai are declining. Conclusion: Although the overall evaluation of the biomedical industry technological innovation capability cannot be completed entirely by patent information, the evaluation of technological innovation ability of biomedical industry based on high-value patents can provide reference for the development of biomedical industry in China.



Key wordsHigh-value patents      Biomedical      Industrial technology innovation capability     
Received: 14 March 2023      Published: 02 November 2023
ZTFLH:  Q81  
  R318  
Cite this article:

WANG Li-wei, YUAN Yin-chi, MAO Kai-yun, LU Jiao. Evaluation of Biomedical Industry Technological Innovation Capability Based on High-value Patents. China Biotechnology, 2023, 43(10): 120-128.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2303037     OR     https://manu60.magtech.com.cn/biotech/Y2023/V43/I10/120

一级指标 二级指标 三级指标
产业技术创新投入A1 24.26% 人才资源指标A11 56.71% 发明人数量指标B1 55.38%
发明人增长率指标B2 44.62%
机构资源指标A12 43.29% 申请人数量指标B3 40.12%
申请人增长率指标B4 59.88%
产业技术创新产出A2 15.88% 产出数量指标A21 42.92% 专利申请数量指标B5 40.83%
专利申请增长率指标B6 59.17%
产出范围指标A22 57.08% 地域范围指标B7 38.35%
技术范围指标B8 61.65%
产业技术创新质量A3 59.86% 技术层面指标A31 33.97% 专利被引数量指标B9 61.04%
权利要求数量指标B10 38.96%
经济层面指标A32 37.92% 美日欧三方专利占比指标B11 37.11%
转让/许可/质押占比指标B12 62.89%
战略层面指标A33 28.11% 同族专利指标B13 46.43%
专利深度指标B14 53.57%
Table 1 Indicator system and indicator weight of Industrial technological innovation capability based on high-value patents
Fig.1 Top 10 provinces (cities) of Chinese biomedicine high-value patents
时间段 指标 江苏 北京 广东 山东 浙江 上海
2006-2010年 发明人数量指标 0.097 8 0.174 7 0.107 8 0.061 7 0.073 9 0.115 5
发明人增长率指标 0.336 1 0.233 1 0.247 1 0.393 9 0.354 2 0.240 4
人才资源指标 0.204 1 0.200 8 0.167 0 0.209 9 0.199 0 0.171 2
申请人数量指标 0.081 1 0.133 9 0.093 4 0.053 0 0.066 6 0.097 1
申请人增长率指标 0.341 6 0.264 3 0.241 7 0.341 3 0.422 5 0.308 4
机构资源指标 0.237 1 0.212 0 0.182 2 0.225 6 0.279 8 0.223 6
2011-2015年 发明人数量指标 0.129 2 0.135 0 0.108 3 0.112 2 0.078 8 0.098 1
发明人增长率指标 0.275 8 0.129 9 0.213 1 0.278 7 0.163 2 0.176 4
人才资源指标 0.194 6 0.132 7 0.155 1 0.186 5 0.116 5 0.133 0
申请人数量指标 0.101 2 0.094 9 0.093 1 0.113 3 0.069 8 0.073 0
申请人增长率指标 0.318 3 0.058 6 0.326 6 0.535 9 0.183 0 0.078 1
机构资源指标 0.231 2 0.073 2 0.232 9 0.366 4 0.137 5 0.076 1
2016-2020年 发明人数量指标 0.147 2 0.124 8 0.136 9 0.087 8 0.084 2 0.084 2
发明人增长率指标 0.281 0 0.068 9 0.474 3 0.244 5 0.304 8 0.304 8
人才资源指标 0.206 9 0.099 9 0.287 4 0.157 7 0.182 6 0.016 4
申请人数量指标 0.109 9 0.094 6 0.125 9 0.074 9 0.075 0 0.070 7
申请人增长率指标 0.829 9 -0.395 2 1.819 0 0.349 0 0.373 3 -0.999 6
机构资源指标 0.541 0 -0.198 7 1.139 7 0.239 0 0.253 6 -0.570 2
Table 2 Score of industrial technology innovation investment indicators
时间段 江苏 北京 广东 山东 浙江 上海
2006-2010年 0.218 4 0.205 6 0.175 3 0.216 7 0.233 9 0.193 9
2011-2015年 0.210 4 0.107 0 0.188 8 0.264 4 0.125 6 0.108 4
2016-2020年 0.351 5 -0.029 4 0.656 4 0.192 9 0.213 3 -0.237 5
Table 3 Evaluation results industrial technology innovation investment indicators
时间段 指标 江苏 北京 广东 山东 浙江 上海
2006-2010年 专利申请数量指标 0.087 5 0.171 8 0.105 1 0.058 0 0.063 2 0.099 2
专利申请增长率指标 0.348 6 0.232 0 0.290 5 0.438 4 0.356 9 0.221 5
产出数量指标 0.242 0 0.207 4 0.214 8 0.283 1 0.237 0 0.171 5
地域范围指标 0.048 0 0.135 4 0.029 5 0.015 1 0.028 6 0.121 9
技术范围指标 0.389 5 0.516 9 0.513 1 0.254 7 0.367 0 0.457 0
产出范围指标 0.258 6 0.370 6 0.327 7 0.162 8 0.237 2 0.281 7
2011-2015年 专利申请数量指标 0.119 2 0.123 0 0.099 0 0.091 8 0.068 1 0.081 7
专利申请增长率指标 0.257 3 0.107 3 0.184 6 0.295 0 0.187 9 0.182 7
产出数量指标 0.200 9 0.113 7 0.149 6 0.212 0 0.139 0 0.141 5
地域范围指标 0.073 9 0.104 4 0.065 9 0.019 6 0.032 6 0.113 6
技术范围指标 0.534 4 0.580 3 0.557 4 0.370 5 0.400 0 0.459 0
产出范围指标 0.357 9 0.397 8 0.368 9 0.235 9 0.259 1 0.283 0
2016-2020年 专利申请数量指标 0.133 9 0.115 0 0.120 6 0.074 2 0.071 8 0.072 5
专利申请增长率指标 0.555 9 -0.130 7 0.695 8 0.342 6 0.314 6 -0.230 7
产出数量指标 0.383 5 -0.030 4 0.461 0 0.233 0 0.215 5 -0.106 9
地域范围指标 0.096 1 0.083 0 0.096 1 0.017 2 0.035 3 0.104 9
技术范围指标 0.507 3 0.527 7 0.568 5 0.387 8 0.466 5 0.437 4
产出范围指标 0.349 6 0.357 2 0.387 3 0.245 7 0.301 1 0.269 6
Table 4 Score of industrial technology innovation output indicators
时间段 江苏 北京 广东 山东 浙江 上海
2006-2010年 0.251 4 0.300 5 0.279 2 0.214 4 0.237 1 0.234 4
2011-2015年 0.290 5 0.275 9 0.274 8 0.225 7 0.207 6 0.222 2
2016-2020年 0.364 1 0.190 8 0.418 9 0.240 2 0.264 4 0.108 0
Table 5 Evaluation results industrial technology innovation output indicators
时间段 指标 江苏 北京 广东 山东 浙江 上海
2006-2010年 专利被引数量指标 0.092 4 0.180 9 0.117 6 0.062 5 0.066 8 0.097 4
权利要求数量指标 0.067 0 0.211 4 0.110 5 0.043 3 0.050 2 0.122 7
技术层面指标 0.082 5 0.192 8 0.114 8 0.055 0 0.060 3 0.107 3
三方专利占比指标 0.063 0 0.194 5 0.033 7 0.020 2 0.038 4 0.187 0
转让/许可/质押占比指标 0.095 5 0.170 9 0.112 8 0.071 9 0.067 7 0.116 8
经济层面指标 0.083 4 0.179 7 0.083 5 0.052 7 0.056 9 0.142 9
同族专利指标 0.073 4 0.160 6 0.084 7 0.024 3 0.035 5 0.121 0
专利深度指标 0.293 4 0.514 0 0.290 4 0.116 6 0.141 9 0.483 9
战略层面指标 0.191 3 0.349 9 0.194 9 0.073 7 0.092 5 0.315 4
2011-2015年 专利被引数量指标 0.128 1 0.130 5 0.112 2 0.089 7 0.067 9 0.080 1
权利要求数量指标 0.102 1 0.178 0 0.112 7 0.052 8 0.053 3 0.116 5
技术层面指标 0.117 9 0.149 0 0.112 4 0.075 3 0.062 2 0.094 3
三方专利占比指标 0.101 9 0.155 2 0.089 9 0.024 1 0.042 5 0.166 8
转让/许可/质押占比指标 0.136 7 0.110 7 0.106 4 0.139 7 0.073 9 0.089 2
经济层面指标 0.123 8 0.127 2 0.100 3 0.096 8 0.062 2 0.118 0
同族专利指标 0.097 4 0.118 7 0.098 5 0.031 1 0.046 0 0.122 4
专利深度指标 0.438 5 0.337 3 0.313 0 0.119 9 0.177 4 0.367 2
战略层面指标 0.280 2 0.235 8 0.213 4 0.078 6 0.116 4 0.253 5
2016-2020年 专利被引数量指标 0.139 8 0.128 7 0.135 4 0.076 1 0.070 5 0.078 0
权利要求数量指标 0.132 6 0.152 4 0.141 0 0.065 2 0.056 9 0.092 4
技术层面指标 0.137 0 0.137 9 0.137 6 0.071 8 0.065 2 0.083 6
三方专利占比指标 0.109 5 0.126 5 0.089 4 0.018 6 0.042 2 0.154 2
转让/许可/质押占比指标 0.140 3 0.128 6 0.130 5 0.099 4 0.085 3 0.107 8
经济层面指标 0.128 9 0.127 8 0.115 2 0.069 4 0.069 3 0.125 0
同族专利指标 0.131 7 0.104 1 0.108 5 0.031 4 0.046 8 0.114 0
专利深度指标 0.452 9 0.409 2 0.426 4 0.115 2 0.214 5 0.348 3
战略层面指标 0.303 8 0.267 5 0.278 8 0.076 3 0.136 6 0.239 5
Table 6 Score of industrial technology innovation quality indicators
时间段 江苏 北京 广东 山东 浙江 上海
2006-2010年 0.113 4 0.232 0 0.125 4 0.059 4 0.068 1 0.179 3
2011-2015年 0.165 8 0.165 1 0.136 2 0.084 4 0.077 4 0.148 0
2016-2020年 0.180 8 0.170 5 0.168 8 0.072 2 0.086 8 0.143 2
Table 7 Evaluation results industrial technology innovation quality indicators
时间段 指标 江苏 北京 广东 山东 浙江 上海
2006-2010年 产业技术创新投入 0.218 4 0.205 6 0.175 3 0.216 7 0.233 9 0.193 9
产业技术创新产出 0.251 4 0.300 5 0.279 2 0.214 4 0.237 1 0.234 4
产业技术创新质量 0.113 4 0.232 0 0.125 4 0.059 4 0.068 1 0.179 3
产业技术创新能力 0.160 8 0.236 5 0.161 9 0.122 2 0.135 2 0.191 6
2011-2015年 产业技术创新投入 0.210 4 0.107 0 0.188 8 0.264 4 0.125 6 0.108 4
产业技术创新产出 0.290 5 0.275 9 0.274 8 0.225 7 0.207 6 0.222 2
产业技术创新质量 0.165 8 0.165 1 0.136 2 0.084 4 0.077 4 0.148 0
产业技术创新能力 0.196 4 0.168 6 0.171 0 0.150 5 0.109 8 0.150 2
2016-2020年 产业技术创新投入 0.351 5 -0.029 4 0.656 4 0.192 9 0.213 3 -0.237 5
产业技术创新产出 0.364 1 0.190 8 0.418 9 0.240 2 0.264 4 0.108 0
产业技术创新质量 0.180 8 0.170 5 0.168 8 0.072 2 0.086 8 0.143 2
产业技术创新能力 0.251 3 0.125 3 0.326 8 0.128 1 0.145 7 0.045 2
Table 8 Evaluation results industrial technology innovation capability
[1]   陈荣, 李建辉, 孙济庆. 基于专利信息分析的区域技术创新能力研究. 科技与经济, 2013, 26(2): 36-40.
[1]   Chen R, Li J H, Sun J Q. Research on regional technology innovation ability based on patent information analysis. Science & Technology and Economy, 2013, 26(2): 36-40.
[2]   傅俊英, 郑佳, 袁芳. 中国PCT国际专利申请后的状况分析. 全球科技经济瞭望, 2018, 33(8): 38-45.
[2]   Fu J Y, Zheng J, Yuan F. Analysis on post-process of China’s patent applications under the patent cooperation treaty. Global Science, Technology and Economy Outlook, 2018, 33(8): 38-45.
[3]   罗先盛, 杨尚伟, 吴永杰. 从专利角度看重庆产业创新能力. 科技和产业, 2017, 17(1): 9-12, 83.
[3]   Luo X S, Yang S W, Wu Y J. Study on the industrial innovation capability of Chongqing from the perspective of patent. Science Technology and Industry, 2017, 17(1): 9-12, 83.
[4]   Bode E. The spatial pattern of localized R&D spillovers: an empirical investigation for Germany. Journal of Economic Geography, 2004, 4(1): 43-64.
doi: 10.1093/jeg/4.1.43
[5]   Ernst H. Patent information for strategic technology management. World Patent Information, 2003, 25(3): 233-242.
[6]   王燕玲. 基于专利分析的行业技术创新研究: 理论关联. 科学学研究, 2008, 26(S2): 496-500.
[6]   Wang Y L. Technology innovation research of particular technology area on the basis of patent analysis: theoretical relationship. Studies in Science of Science, 2008, 26(S2): 496-500.
[7]   杨中楷, 沈露威. 基于有效专利指标的区域创新能力评价. 科技与经济, 2010, 23(1): 30-33.
[7]   Yang Z K, Shen L W. Estimate of regional innovation capability based on patents in force index. Science & Technology and Economy, 2010, 23(1): 30-33.
[8]   龚关. 基于专利信息的产业技术创新能力评价研究. 上海: 华东师范大学, 2012.
[8]   Gong G. Research on evaluation for technology innovation capacity of industry based on the patents. Shanghai: East China Normal University, 2012.
[9]   谭清立, 林岱衡, 刘珈瑗, 等. 基于灰色综合关联分析法的粤港澳大湾区生物医药产业效益研究. 中国生物工程杂志, 2021, 41(6): 89-97.
[9]   Tan Q L, Lin D H, Liu J Y, et al. Study on the benefits of biomedical industry in the Guangdong-Hong Kong-Macao greater bay area based on grey comprehensive correlation analysis. China Biotechnology, 2021, 41(6): 89-97.
[10]   朱雪忠. 我国专利数量的失控及其危害. [2023-03-07]. https://mp.weixin.qq.com/s/FDVotU6_ZNF7i93-_2V7pw.
[10]   Zhu X Z. The loss of control and harm of the number of patents in China. [2023-03-07]. https://mp.weixin.qq.com/s/FDVotU6_ZNF7i93-_2V7pw.
[11]   国务院. 国务院关于印发“十四五”国家知识产权保护和运用规划的通知. [2023-04-04]. http://www.gov.cn/zhengce/content/2021-10/28/content_5647274.htm.
[11]   The State Council. Notice of the State Council on issuing the national intellectual property protection and application plan for the 14th five year plan. [2023-04-04]. http://www.gov.cn/zhengce/content/2021-10/28/content_5647274.htm.
[12]   彭小宝, 陈文清. 我国高价值发明专利界定标准研究. 科技与法律(中英文), 2021(6): 58-64.
[12]   Peng X B, Chen W Q. Study on the definition standards of high-value invention patents. Science Technology and Law (Chinese-English Version), 2021(6): 58-64.
[13]   衣春波, 赵文华, 邓璐芗, 等. 基于专利信息的技术创新策源评价指标体系构建与应用. 情报杂志, 2021, 40(2): 55-62.
[13]   Yi C B, Zhao W H, Deng L X, et al. Construction and application of evaluation index system of technology innovation cradle based on patent information. Journal of Intelligence, 2021, 40(2): 55-62.
[14]   陈雅雪, 罗古月. 高等农业院校专利技术创新能力研究. 沈阳农业大学学报(社会科学版), 2015, 17(1): 24-28.
[14]   Chen Y X, Luo G Y. On the innovative ability of patented technologies in agricultural colleges and universities. Journal of Shenyang Agricultural University (Social Science Edition), 2015, 17(1): 24-28.
[15]   Lerner J. The importance of patent scope: an empirical analysis. The RAND Journal of Economics, 1994, 25(2): 319-333.
doi: 10.2307/2555833
[16]   赵文华. 基于专利信息分析的上海技术创新策源能力评价研究. 上海: 华东师范大学, 2020.
[16]   Zhao W H. Research on the evaluation of Shanghai’s original innovation capabilities based on patent information analysis. Shanghai: East China Normal University, 2020.
[17]   Karki M M S. Patent citation analysis: a policy analysis tool. World Patent Information, 1997, 19(4): 269-272.
[18]   俞媛媛. 基于有效专利的专利丛林测度与应用研究. 大连: 大连理工大学, 2016.
[18]   Yu Y Y. Study on measurement and application for patent thickets based on valid patents. Dalian: Dalian University of Technology, 2016.
[19]   许鑫, 赵文华, 姚占雷. 多维视角的高质量专利识别及其应用研究. 现代情报, 2019, 39(11): 13-22, 45.
doi: 10.3969/j.issn.1008-0821.2019.11.002
[19]   Xu X, Zhao W H, Yao Z L. Research on the identification and application of high-quality patents: from the perspective of multiple dimensions. Modern Information, 2019, 39(11): 13-22, 45.
doi: 10.3969/j.issn.1008-0821.2019.11.002
[1] WANG Lin,CHEN Ya-ru,CHENG Mei-jie,SONG Hao,CAO Ying-xiu. Research Advances in Microbial Chitinase and Its Applications[J]. China Biotechnology, 2022, 42(12): 101-110.
[2] ZHANG Zheng-yan,CHEN Yu,SONG Li-jie,SU Zheng-quan,ZHANG Hai-yan. Advances in the Application of Field Effect Transistor Biosensor in Biomedical Detection[J]. China Biotechnology, 2021, 41(10): 73-88.
[3] YIN Zheng-qing,BAI Jing-yu,LIN Xiao-feng. Competitiveness Analysis and Enlightenment of Biomedical Industry in USA[J]. China Biotechnology, 2020, 40(9): 87-94.
[4] HUANG Peng-fei,CHEN Yun,LU Jiao,MAO Kai-yun,YUAN Yin-chi. Development Situation and Suggestions of Biomedicine Patent-intensive Industry, Based on the Case Study of Shanghai[J]. China Biotechnology, 2020, 40(12): 108-116.
[5] Fang-xu WANG,Yu-ling CHEN,Du-yan GENG,Chuan-fang CHEN. Research Progress on Biomedical Applications of Magnetotactic Bacteria and the Biosynthetic Magnetosomes[J]. China Biotechnology, 2018, 38(9): 74-80.
[6] PU Run, LI Ping-ping, SU Yue, ZHU Min, HUA Yu-tao. Development Statuses and Future Suggestions of Biomedical Parks in China[J]. China Biotechnology, 2015, 35(3): 104-106.
[7] MEI Jian-guo, ZHUANG Jin-qiu, WANG Jin-liang, WANG Yu-mao, DING Zhuang, SHEN Zhi-qiang. Advance of Large-scale Animal Cell Culture Technology[J]. China Biotechnology, 2012, 32(07): 127-132.
[8] ZHAO Bing, ZHANG Dong-sheng, ZHAO Yong-zheng. Research on The Competitiveness of Regional Biomedical Industry——Taking Shijiazhuang as Example[J]. China Biotechnology, 2011, 31(9): 140-145.
[9] HUANG Kai-Zong, WANG Wen-Xing, ZHANG Guang-E. Advances in Applications of Elastin-like Polypeptides in Biomedical Materials[J]. China Biotechnology, 2010, 30(05): 128-132.
[10] . [J]. China Biotechnology, 1998, 18(6): 3-10.